Related Experiment Video
Updated: Oct 27, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in
Laura Keil1, Céleste Chevalier1, Paulus Kirchhof1,2
1Clinic for Cardiology, University Heart and Vascular Center Hamburg Eppendorf, 20246 Hamburg, Germany.
Insights
Non-ischemic cardiomyopathy (NICM) patients may benefit from implantable cardioverter-defibrillators (ICDs). Cardiovascular magnetic resonance imaging (CMR) aids in identifying NICM patients who will benefit most from ICD therapy for sudden cardiac death prevention.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Non-ischemic cardiomyopathy (NICM) is a significant cause of sudden cardiac death (SCD).
- Current guidelines do not differentiate ICD implantation recommendations between NICM and ischemic cardiomyopathy (ICM).
- Improved risk stratification is needed for NICM patients to identify those who benefit from ICD therapy.
Purpose of the Study:
- To review the epidemiological aspects of SCD in NICM.
- To evaluate the role of cardiovascular magnetic resonance imaging (CMR) in risk stratification for SCD in NICM.
- To discuss resulting indications for implantable cardioverter-defibrillator (ICD) implantation in NICM.
Main Methods:
- Review of existing epidemiological data on SCD in NICM.
- Analysis of studies investigating CMR parameters (late gadolinium enhancement, T1 relaxation times, myocardial strain) for SCD risk stratification.
- Evaluation of established predictors (genetic mutations, LVEF, LVEDD, TWA) alongside CMR findings.
Main Results:
- CMR offers comprehensive analysis of cardiac function and myocardial tissue composition, potentially improving risk stratification.
- Specific CMR parameters like LGE, T1 relaxation times, and myocardial strain are associated with SCD risk in NICM.
- Integrating CMR with clinical and genetic predictors may refine patient selection for ICD therapy.
Conclusions:
- Cardiovascular magnetic resonance imaging (CMR) shows promise in enhancing risk stratification for sudden cardiac death (SCD) in non-ischemic cardiomyopathy (NICM).
- Further research integrating CMR with other predictors can optimize implantable cardioverter-defibrillator (ICD) implantation decisions in NICM patients.
- Personalized risk assessment using advanced imaging is crucial for preventing SCD in NICM.
Abstract:
Non-ischemic cardiomyopathy (NICM) is one of the most important entities for arrhythmias and sudden cardiac death (SCD). Previous studies suggest a lower benefit of implantable cardioverter-defibrillator (ICD) therapy in patients with NICM as compared to ischemic cardiomyopathy (ICM). Nevertheless, current guidelines do not differentiate between the two subgroups in recommending ICD implantation. Hence, risk stratification is required to determine the subgroup of patients with NICM who will likely benefit from ICD therapy. Various predictors have been proposed, among others genetic mutations, left-ventricular ejection fraction (LVEF), left-ventricular end-diastolic volume (LVEDD), and T-wave alternans (TWA). In addition to these parameters, cardiovascular magnetic resonance imaging (CMR) has the potential to further improve risk stratification. CMR allows the comprehensive analysis of cardiac function and myocardial tissue composition. A range of CMR parameters have been associated with SCD. Applicable examples include late gadolinium enhancement (LGE), T1 relaxation times, and myocardial strain. This review evaluates the epidemiological aspects of SCD in NICM, the role of CMR for risk stratification, and resulting indications for ICD implantation.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care